Epstein Secrets

are on." Eric Dash contributed reporting forthis article. <<Previous I 1 12 TOP NYTIMES.COM ARTICLES • Jrao's Premier Is Asked to Quit as Shiites Solit • Labor Shortage in China May Lead to Trade Shift • New York City Losing Blacks. Census Shows • In Death of Bronx Charter School. a Wi Jai= Go to

(May 2000) Current esldents at Address: Cur • DOS: sle: xxx-wt-mca issued in NEW JERSEY between-m101/1966 and 12/31/1967 Relative: DOB: Age:. EW JERSEY betwee 1/01/1966 and 12/31/1967 DOS:as EW JERSEY betwee 1/01/1968 and 12/31/1969 B:nge: ERSEY betwee 1/ >x<-xx- issued in NEW JERSEY betw en

1/1969 :coc-m-xmoc issued in NEW JERSEY s /0 966 and 12/31/1967 08: Age: RS: 886 966 and 12/31/1967 : S. D06 Age: >ooc->oc-xxxx issued in NEW JERS between 01/ 966 and 12/31/1967 DOB: Age: :opc-mc-)cocc issued in NEW JERSEY between 01/0 968 and 12/31/1967 d Non-Verified Address(es): ALIFO

d've been absurdly time-consuming and expen- sive. Now the sequencing takes as little as a few days. Poring over the outlier patient's genetic code, Solit pinpointed two mutations that made her tumor sensi- five to this drug. He found that one of her mutations shows up in about 8 to 10 percent of othe

05751 EFTA00805752 NIAT TER :SI( t. Frack 'er Up Natural gas is shaking up the search for green gasoline BY DAVID BIELLO I AM SPEEDING DOWN New Jersey's highways, propelled by gasoline with a dash of ethanol, an alcoholic biofuel brewed from stewed corn ker- - nels. As I drive through the outskirts

O Lc --- PAGE BREAK --- MATTER B IOFUEL Frack ’er Up Natural gas is shaking up the search for green gasoline BY DAVID BIELLO AM SPEEDING DOWN New Jersey’s highways, | propelled by gasoline with a dash of ethanol, an alcoholic biofuel brewed from stewed corn ker- ~~ nels. As I drive through the outskirt

d’ve been absurdly time-consuming and expen- sive. Now the sequencing takes as little as a few days. Poring over the outlier patient’s genetic code, Solit pinpointed two mutations that made her tumor sensi- tive to this drug. He found that one of her mutations shows up in about 8 to 10 percent of other

genome sequenc- ing 1s being used to help people with relapsed cancers and who have run out of options. The project puts insights from stud- ies like Solit’s into practice, analyzing a patient’s tumor to determine whether currently available drugs might target the troublemaker mutations. Combining whole